LSK Investment
Overview
LSK Investment is a venture capital firm based in Seoul, South Korea, founded in 2016. The firm specializes in the healthcare sector, investing in companies operating in pharmaceuticals, medical devices, medical services, and convergence technologies. It was founded by professionals with deep domain expertise in biotechnology and life sciences.
Portfolio Companies
6
Website
lskinvestment.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Rznomics Inc. | Sep 2019 | Series A | - |
| Lemon Healthcare | Mar 2018 | Series A | - |
| Trioar | May 2023 | Series A | Lead |
| CTCELLS | Mar 2022 | Series B | Co-investor |
| Avelos Therapeutics | Apr 2024 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is LSK Investment based?
LSK Investment is headquartered in Seoul, Seoul, South Korea.
When was LSK Investment founded?
Founding year information for LSK Investment is not publicly available.
How many portfolio companies does LSK Investment have?
LSK Investment has 6 portfolio companies in Caplight's dataset.
What are some companies in LSK Investment's portfolio?
Portfolio companies visible on Caplight include Rznomics Inc., Lemon Healthcare, Trioar, CTCELLS, Avelos Therapeutics.
What was LSK Investment's most recent investment shown here?
LSK Investment's most recent investment in this portfolio sample was in Avelos Therapeutics in 2024.
What sectors does LSK Investment focus on?
LSK Investment focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Telecommunications & Networking, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Consumer & Commerce.
What company stages does LSK Investment focus on?
LSK Investment typically invests at the Early stage.
What is LSK Investment's AUM?
LSK Investment's assets under management are estimated between $150.2M and $160.0M.